# Biomat USA, Inc – FDA Inspection, Dec 3, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/dc9ee5c3-dbdc-40a7-843d-a31698f5b5c2
Source feed: FDA_Inspections

> FDA inspection 1073344 of Biomat USA, Inc, December 03, 2018. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 600, 606 and 630. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1073344
- Company Name: Biomat USA, Inc
- Inspection Date: 2018-12-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1149030 - 2021-07-23
- FDA Inspection 984570 - 2016-09-14
- FDA Inspection 892304 - 2014-08-21
- FDA Inspection 783979 - 2012-06-06
- FDA Inspection 654445 - 2010-03-19

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/elmina-e-akwo/ecd9066d-1647-4765-ad86-dbe5280241c5)
- [FDA Associated Person](https://www.keypedia.com/people/lauren-m-lilly/41582ad0-67b1-4c60-99e2-c1e3c63811c2)

Company: https://www.keypedia.com/companies/biomat-usa-inc/e79225e2-3a22-4b84-8982-ec052660207d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d